← Oncology Approval Tracker

FDA DECISION ·

Opdivo

nivolumab · Bristol Myers Squibb

Traditional approvalTraditional conversionClassical Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with relapsed or refractory classical Hodgkin lymphoma after autologous stem-cell transplant and brentuximab vedotin.

LAMPGEN ANALYSIS

Why it matters

This converts a previously accelerated post-transplant indication to traditional approval. The first-line AVD decision announced the same day is a distinct use.

What research teams should watch

Capture the transplant and brentuximab treatment sequence before assigning the approved use. Cite the conversion evidence separately from first-line SWOG 1826 results.

PRIMARY RECORDS

Sources